Am. J. Respir. Cell Mol. Biol., Volume 23, Number 4, October, 2000 444-451

Activation and Transforming Growth Factor- Production in Eosinophils by Hyaluronan

Yuichi Ohkawara, Gen Tamura, Tadashi Iwasaki, Akiko Tanaka, Tadashi Kikuchi, and Kunio Shirato

First Department of Internal Medicine, Tohoku University School of Medicine, Sendai, Japan

To investigate whether extracellular matrix glycosaminoglycan hyaluronan (HA) modulates eosinophil activation and transforming growth factor (TGF)- production by eosinophils, human peripheral blood eosinophils (purity > 99%) from 12 patients with mild to moderate asthma or six healthy subjects were isolated and incubated with increasing concentrations of low molecular weight (mol wt) HA ( 0.2 × 10⁶ D) or high mol wt HA (3.0 to  5.8 × 10⁶ D). We found that the low mol wt HA has a pronounced effect on eosinophil survival in both patients with asthma and healthy subjects in a dose-dependent fashion on Days 2 and 4. Whereas the high mol wt HA had a smaller effect on eosinophil survival than did the low mol wt HA. The HA-mediated eosinophil survival was partially but significantly inhibited ( 50% inhibition) by a blocking monoclonal antibody for CD44, a specific receptor of HA, and largely inhibited by an anti-granulocyte macrophage colony-stimulating factor (GM-CSF) neutralizing antibody but not by an anti-interleukin (IL)-3 or anti-IL-5 neutralizing antibody. In addition, the low mol wt HA increased GM-CSF messenger RNA (mRNA) expression and protein secretion by eosinophils in a dose-dependent fashion, suggesting that the HA-mediated eosinophil survival is due mainly to induction of GM-CSF release through partial CD44 signaling. Furthermore, we demonstrated that the low mol wt HA results in morphologic changes in eosinophils such as transforming from a round to a spindle shape and in homotypic aggregation, upregulates intercellular adhesion molecule-1 expression, and increases TGF- mRNA expression and protein secretion by eosinophils. These observations suggest previously unforeseen interactions between eosinophils and low mol wt extracellular matrix and, thus, novel pathways by which eosinophils may contribute to the regulation of airway inflammation and airway remodeling.

This article has been cited by other articles:

				P. W. Noble and D. Jiang Matrix regulation of lung injury, inflammation, and repair: the role of innate immunity. Proceedings of the ATS, July 1, 2006; 3(5): 401 - 404. [Abstract] [Full Text] [PDF]

				M A Dentener, R Louis, R H E Cloots, M Henket, and E F M Wouters Differences in local versus systemic TNF{alpha} production in COPD: inhibitory effect of hyaluronan on LPS induced blood cell TNF{alpha} release Thorax, June 1, 2006; 61(6): 478 - 484. [Abstract] [Full Text] [PDF]

				M A Dentener, J H J Vernooy, S Hendriks, and E F M Wouters Enhanced levels of hyaluronan in lungs of patients with COPD: relationship with lung function and local inflammation Thorax, February 1, 2005; 60(2): 114 - 119. [Abstract] [Full Text] [PDF]

				E. Forbes, T. Murase, M. Yang, K. I. Matthaei, J. J. Lee, N. A. Lee, P. S. Foster, and S. P. Hogan Immunopathogenesis of Experimental Ulcerative Colitis Is Mediated by Eosinophil Peroxidase J. Immunol., May 1, 2004; 172(9): 5664 - 5675. [Abstract] [Full Text] [PDF]

				S. Esnault and J. S. Malter Hyaluronic Acid or TNF-{alpha} Plus Fibronectin Triggers Granulocyte Macrophage-Colony-Stimulating Factor mRNA Stabilization in Eosinophils Yet Engages Differential Intracellular Pathways and mRNA Binding Proteins J. Immunol., December 15, 2003; 171(12): 6780 - 6787. [Abstract] [Full Text] [PDF]

				M. Schoenfelder and R. Einspanier Expression of Hyaluronan Synthases and Corresponding Hyaluronan Receptors Is Differentially Regulated During Oocyte Maturation in Cattle Biol Reprod, July 1, 2003; 69(1): 269 - 277. [Abstract] [Full Text] [PDF]

				P. E. Pummill and P. L. DeAngelis Alteration of Polysaccharide Size Distribution of a Vertebrate Hyaluronan Synthase by Mutation J. Biol. Chem., May 23, 2003; 278(22): 19808 - 19814. [Abstract] [Full Text] [PDF]

				G. M. Turino and J. O. Cantor Hyaluronan in Respiratory Injury and Repair Am. J. Respir. Crit. Care Med., May 1, 2003; 167(9): 1169 - 1175. [Full Text] [PDF]

				R. Altman, R. Moskowitz, D. T. Felson, and J. J. Anderson Hyaluronate Sodium Injections for Osteoarthritis: The Truth Arch Intern Med, November 25, 2002; 162(21): 2498 - 2500. [Full Text] [PDF]

				E. A. Turley, P. W. Noble, and L. Y. W. Bourguignon Signaling Properties of Hyaluronan Receptors J. Biol. Chem., February 8, 2002; 277(7): 4589 - 4592. [Full Text] [PDF]

				D. J. Mahoney, R. T. Aplin, A. Calabro, V. C. Hascall, and A. J. Day Novel methods for the preparation and characterization of hyaluronan oligosaccharides of defined length Glycobiology, December 1, 2001; 11(12): 1025 - 1033. [Abstract] [Full Text] [PDF]

				T. D. Camenisch and J. A. McDonald Hyaluronan . Is Bigger Better? Am. J. Respir. Cell Mol. Biol., October 1, 2000; 23(4): 431 - 433. [Full Text]